The two professors from KULeuven were selected for their innovative bioplastics manufacturing process.
BIO INX, a new spin-off from Ghent University and the VUB, is working on a bio-ink that can be used to 3D-print complex structures such as organs and human tissue based on stem cells.
Developed in the Belgian facilities of GSK's pharmaceutical laboratory, Arexvy is the world's first vaccine to combat Respiratory Syncytial Virus (RSV).
Classic blood pressure inhibitors may also help our immune system fight cancer cells better. This was discovered by scientists from UCLouvain's de Duve Institute, among others.
For the first time in the world, a lymphatic malformation has been treated with a drug administered directly to the mother during pregnancy.
Researchers from the Université libre de Bruxelles (ULB) have discovered a protein, RHOJ, which controls cancer cells' resistance to chemotherapy.